Can you align the heterogeneous range of clinical phenotypes seen in children and adolescents with AD to the appropriate severity-of-disease metrics that would trigger specific therapies?

Can you align the heterogeneous range of clinical phenotypes seen in children and adolescents with AD to the appropriate severity-of-disease metrics that would trigger specific therapies?

Can you align the heterogeneous range of clinical phenotypes seen in children and adolescents with AD to the appropriate severity-of-disease metrics that would trigger specific therapies?


Created by

CMEducation Resources iQ&A Case-By-Case Atopic Dermatitis Medical Intelligence Zone

Presenter

Lawrence Eichenfield, MD

Lawrence Eichenfield, MD

Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital-San Diego
Vice Chair, Department of Dermatology
Professor of Dermatology and Pediatrics
UC San Diego School of Medicine